Scales to evaluate quality of medication management: Development and psychometric properties

Amanda C. Taylor; Gary R. Bond; Jack Tsai; Patricia B. Howard; Peggy El-Mallakh; Molly Finnerty; Edith Kealey; Britt Myrhol; Karin Kalk; Neal Adams; Alexander L. Miller

doi:10.1007/s10488-009-0209-z

Scales to evaluate quality of medication management: Development and psychometric properties

Amanda C. Taylor, Gary R. Bond, Jack Tsai, Patricia B. Howard, Peggy El-Mallakh, Molly Finnerty, Edith Kealey, Britt Myrhol, Karin Kalk, Neal Adams, Alexander L. Miller

Department of Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

Original language	English (US)
Pages (from-to)	247-254
Number of pages	8
Journal	Administration and Policy in Mental Health and Mental Health Services Research
Volume	36
Issue number	4
DOIs	https://doi.org/10.1007/s10488-009-0209-z
State	Published - Jul 2009

Keywords

Antipsychotics
Fidelity measurement
Medication management

ASJC Scopus subject areas

Phychiatric Mental Health
Health Policy
Public Health, Environmental and Occupational Health
Psychiatry and Mental health

Access to Document

10.1007/s10488-009-0209-z

Cite this

Taylor, A. C., Bond, G. R., Tsai, J., Howard, P. B., El-Mallakh, P., Finnerty, M., Kealey, E., Myrhol, B., Kalk, K., Adams, N., & Miller, A. L. (2009). Scales to evaluate quality of medication management: Development and psychometric properties. Administration and Policy in Mental Health and Mental Health Services Research, 36(4), 247-254. https://doi.org/10.1007/s10488-009-0209-z

Taylor, AC, Bond, GR, Tsai, J, Howard, PB, El-Mallakh, P, Finnerty, M, Kealey, E, Myrhol, B, Kalk, K, Adams, N & Miller, AL 2009, 'Scales to evaluate quality of medication management: Development and psychometric properties', Administration and Policy in Mental Health and Mental Health Services Research, vol. 36, no. 4, pp. 247-254. https://doi.org/10.1007/s10488-009-0209-z

@article{8a3cee9b48d14157a52e43105e1d9b3f,

title = "Scales to evaluate quality of medication management: Development and psychometric properties",

abstract = "This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.",

keywords = "Antipsychotics, Fidelity measurement, Medication management",

author = "Taylor, {Amanda C.} and Bond, {Gary R.} and Jack Tsai and Howard, {Patricia B.} and Peggy El-Mallakh and Molly Finnerty and Edith Kealey and Britt Myrhol and Karin Kalk and Neal Adams and Miller, {Alexander L.}",

note = "Funding Information: Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.",

year = "2009",

month = jul,

doi = "10.1007/s10488-009-0209-z",

language = "English (US)",

volume = "36",

pages = "247--254",

journal = "Administration and Policy in Mental Health and Mental Health Services Research",

issn = "0894-587X",

publisher = "Springer New York",

number = "4",

}

TY - JOUR

T1 - Scales to evaluate quality of medication management

T2 - Development and psychometric properties

AU - Taylor, Amanda C.

AU - Bond, Gary R.

AU - Tsai, Jack

AU - Howard, Patricia B.

AU - El-Mallakh, Peggy

AU - Finnerty, Molly

AU - Kealey, Edith

AU - Myrhol, Britt

AU - Kalk, Karin

AU - Adams, Neal

AU - Miller, Alexander L.

N1 - Funding Information: Mt. Sinai School of Medicine). Scale testing was funded by unrestricted educational grants from AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, and Pfizer to Dr. Miller. Initial development of the scale was funded by a contract between Dartmouth Medical School and the Substance Abuse and Mental Health Services Administration for development of evidence-based practice toolkits, with the medication toolkit subcontracted to the University of Texas Health Science Center at San Antonio.

PY - 2009/7

Y1 - 2009/7

N2 - This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

AB - This paper describes the psychometric properties of two fidelity scales created as part of the Substance Abuse and Mental Health Services Administration (SAMHSA) sponsored medication management toolkit and their metric properties when used in 26 public mental health clinics with 50 prescribers. A 23-item scale, based on chart reviews, was developed to assess whether prescribers are following good medication practices, in conjunction with a 17-item scale to assess organizational support for and evaluation of prescriber adherence to recommended medication-related practices. Fundamental gaps in routine practice, including poor documentation of medication history and infrequent monitoring of symptoms and side effects were found.

KW - Antipsychotics

KW - Fidelity measurement

KW - Medication management

UR - http://www.scopus.com/inward/record.url?scp=67449152474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449152474&partnerID=8YFLogxK

U2 - 10.1007/s10488-009-0209-z

DO - 10.1007/s10488-009-0209-z

M3 - Article

C2 - 19247828

AN - SCOPUS:67449152474

SN - 0894-587X

VL - 36

SP - 247

EP - 254

JO - Administration and Policy in Mental Health and Mental Health Services Research

JF - Administration and Policy in Mental Health and Mental Health Services Research

IS - 4

ER -

Scales to evaluate quality of medication management: Development and psychometric properties

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this